MYC and cancer: Although a multitude of innovative treatment modalities is theoretically available for non-WNT/non-SHH MB already and even newer concepts are currently developed, such as refined ways of targeting epigenetic alterations in cancer or strategies to directly target MYC-family genes [104], none of these concepts currently are standing out.